Mainz Biomed N.V.
QUCY
$0.43
-$0.03-6.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 537.20K | 598.60K | 660.00K | 777.00K | 894.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 537.20K | 598.60K | 660.00K | 777.00K | 894.00K |
| Cost of Revenue | 147.40K | 181.00K | 214.60K | 266.90K | 319.20K |
| Gross Profit | 389.80K | 417.60K | 445.40K | 510.10K | 574.80K |
| SG&A Expenses | 8.93M | 10.25M | 11.57M | 12.40M | 13.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.04M | 15.74M | 17.44M | 18.42M | 19.39M |
| Operating Income | -13.50M | -15.14M | -16.78M | -17.64M | -18.50M |
| Income Before Tax | -16.21M | -17.57M | -18.92M | -20.26M | -21.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.21 | -17.57 | -18.92 | -20.26 | -21.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.21M | -17.57M | -18.92M | -20.26M | -21.60M |
| EBIT | -13.50M | -15.14M | -16.78M | -17.64M | -18.50M |
| EBITDA | -12.88M | -14.56M | -16.23M | -17.02M | -17.80M |
| EPS Basic | -3.54 | -6.84 | -10.14 | -18.68 | -27.22 |
| Normalized Basic EPS | -2.02 | -3.80 | -5.58 | -10.62 | -15.66 |
| EPS Diluted | -3.54 | -6.84 | -10.14 | -18.68 | -27.22 |
| Normalized Diluted EPS | -2.02 | -3.80 | -5.58 | -10.62 | -15.66 |
| Average Basic Shares Outstanding | 23.99M | 16.55M | 9.11M | 6.53M | 3.94M |
| Average Diluted Shares Outstanding | 23.99M | 16.55M | 9.11M | 6.53M | 3.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |